Kvaerner has secured two contracts with a combined value in excess of USD 55 million, from two customers, for two new bio-pharmaceutical manufacturing projects in the NE U.S.A. Kvaerner
will undertake the engineering, procurement, construction management, and validation work for both projects. The projects represent a total capital investment by the customers in excess of USD 500 million, and will be undertaken from Kvaerner’s New Jersey operation. Work will start this month on both projects.
